KBC Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,828
| Closed | -$10K | – | 1877 |
|
|
2023
Q3 | $10K | Sell |
2,828
-422
| -13% | -$1.49K | ﹤0.01% | 1915 |
|
|
2023
Q2 | $24K | Sell |
3,250
-911
| -22% | -$6.73K | ﹤0.01% | 1458 |
|
|
2023
Q1 | $43K | Hold |
4,161
| – | – | ﹤0.01% | 1416 |
|
|
2022
Q4 | $49K | Hold |
4,161
| – | – | ﹤0.01% | 1394 |
|
|
2022
Q3 | $87K | Sell |
4,161
-453
| -10% | -$9.47K | ﹤0.01% | 1241 |
|
|
2022
Q2 | $143K | Buy |
+4,614
| New | +$143K | ﹤0.01% | 1086 |
|
|
2021
Q4 | – | Sell |
-471
| Closed | -$24K | – | 1301 |
|
|
2021
Q3 | $24K | Sell |
471
-1,215
| -72% | -$61.9K | ﹤0.01% | 1282 |
|
|
2021
Q2 | $106K | Hold |
1,686
| – | – | ﹤0.01% | 1222 |
|
|
2021
Q1 | $156K | Hold |
1,686
| – | – | ﹤0.01% | 1207 |
|
|
2020
Q4 | $831K | Hold |
1,686
| – | – | ﹤0.01% | 1167 |
|
|
2020
Q3 | $174K | Hold |
1,686
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q2 | $134K | Buy |
1,686
+843
| +100% | +$67K | ﹤0.01% | 1191 |
|
|
2020
Q1 | $49K | Sell |
843
-1,768
| -68% | -$103K | ﹤0.01% | 1200 |
|
|
2019
Q4 | $141K | Hold |
2,611
| – | – | ﹤0.01% | 1322 |
|
|
2019
Q3 | $137K | Hold |
2,611
| – | – | ﹤0.01% | 1309 |
|
|
2019
Q2 | $126K | Buy |
+2,611
| New | +$126K | ﹤0.01% | 1290 |
|
|
2015
Q1 | – | Sell |
-3,663
| Closed | -$100K | – | 1367 |
|
|
2014
Q4 | $100K | Buy |
+3,663
| New | +$100K | ﹤0.01% | 1316 |
|
|
2014
Q2 | – | Sell |
-2,180
| Closed | -$55K | – | 1341 |
|
|
2014
Q1 | $55K | Hold |
2,180
| – | – | ﹤0.01% | 1205 |
|
|
2013
Q4 | $50K | Buy |
+2,180
| New | +$50K | ﹤0.01% | 1223 |
|